Restart Life Science

Pilz Bioscience Corp. is a biotechnology company based in Vancouver, Canada, focused on developing diagnostic and therapeutic solutions for neuro-inflammatory conditions with significant unmet medical needs. Established in 2020, the company specializes in medicinal psychedelics aimed at optimizing cellular function and modifying cognitive perception. Pilz's initial efforts target Autism Spectrum Disorder (ASD) but also extend to conditions such as PTSD, treatment-resistant depression, and anxiety disorders. By employing a systems-level scientific approach that considers inflammation, the gut-brain axis, and behavior, Pilz Bioscience seeks to create effective diagnostic and monitoring programs alongside first-in-class therapeutics for these challenging conditions.